Pathophysiology of Bone Loss in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy and Lifestyle Modifications for the Management of Bone Health: A Comprehensive Review

Pathophysiology of Bone Loss in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy and Lifestyle Modifications for the Management of Bone Health: A Comprehensive Review

Androgen-deprivation therapy (ADT) is a systemic therapy administered for the management of advanced prostate cancer (PCa). Although ADT may improve survival, long-term use reduces bone mass density (BMD), posing an increased risk of fracture. Considering the long natural history of PCa, it is essen...

Full description

Bibliographic Details
Main Authors: Tae Jin Kim, Kyo Chul Koo
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Cancers
Subjects:
androgen
bone diseases
endocrine
lifestyle
prostatic neoplasm
quality of life
Online Access:https://www.mdpi.com/2072-6694/12/6/1529

Internet

https://www.mdpi.com/2072-6694/12/6/1529

Similar Items